newsfilter
← Latest News
Business Wire·

Vor Biopharma Appoints David Lubner to Its Board of Directors

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, today announced the appointment of David Lubner, a senior finance executive with over 25 years of experience, to Vor’s Board of Directors.